We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 648 results
  1. Epidemiology, antifungal susceptibility, risk factors, and mortality of persistent candidemia in adult patients in China: a 6-year multicenter retrospective study

    Background

    Data on persistent candidemia (PC), a recognized complication of candidemia, are lacking in China. This study aimed to investigate the...

    Yan** Li, Chenghong Gu, ... Zhangrui Zeng in BMC Infectious Diseases
    Article Open access 01 June 2023
  2. Candidemia in patients with head and neck cancer: mortality and a novel risk factor

    Purpose

    Candidemia is a bloodstream infection (BSI) by Candida spp. and is associated with high mortality. However, there have been few reports about...

    Kensuke Uraguchi, Takuma Makino, ... Mizuo Ando in Supportive Care in Cancer
    Article 06 April 2022
  3. Factors associated with the development of ocular candidiasis and ocular prognosis with echinocandin therapy for candidemia

    Purpose

    To evaluate the factors associated with the development of ocular candidiasis (OC) and ocular prognosis with echinocandin therapy for...

    Daiki Sakai, Wataru Matsumiya, ... Makoto Nakamura in Journal of Ophthalmic Inflammation and Infection
    Article Open access 14 June 2021
  4. Risk factors and outcomes associated with persistent vancomycin resistant Enterococcal Bacteremia

    Background

    Prior studies have identified that vancomycin resistant enterococcus (VRE) bacteremia that persists for four days or more is an independent...

    Emily Fox, David Ha, ... William Alegria in BMC Infectious Diseases
    Article Open access 16 November 2022
  5. A Sco** Review of the Changing Epidemiology and Risk Factors of Endogenous Candida Ocular Infections

    Purpose of Review

    There is controversy surrounding the true incidence of ocular infection in patients with candidemia and the best approach to...

    Zachary Pek, Jacqueline T. Bork in Current Fungal Infection Reports
    Article 26 July 2023
  6. Candidemia in patients with cardiovascular implantable electronic devices

    Purpose

    Current guidelines recommend complete extraction of cardiovascular implantable electronic devices (CIEDs) in the case of persistent or...

    Tomofumi Nakamura, Ryohsuke Narui, ... Jay A. Montgomery in Journal of Interventional Cardiac Electrophysiology
    Article 11 February 2020
  7. Pharmacological options for Candida albicans Endocarditis at the roadblock with irrecoverable prosthetics and drug interactions: a case report and review of literature

    Background

    Candidemia is the fourth most common nosocomial bloodstream infection. Endocarditis from candidemia is a rare but possibly fatal...

    Syeda Sahra, Aneeqa Javed, ... Sharanjeet K. Thind in BMC Infectious Diseases
    Article Open access 08 May 2023
  8. Candida auris Blood stream infection- a descriptive study from Qatar

    Background

    Candida auris is an emerging yeast pathogen that can cause invasive infections, particularly candidemia, in healthcare settings. Candida...

    Junais Koleri, Hawabibee Mahir Petkar, ... Muna A. Rahman S. AlMaslamani in BMC Infectious Diseases
    Article Open access 06 August 2023
  9. Epidemiology, clinical characteristics, and outcome of candidemia in critically ill patients in Germany: a single-center retrospective 10-year analysis

    Background

    Despite advances in the management of bloodstream infections (BSI) caused by Candida spp., the mortality still remains high in critically...

    Maria Schroeder, Theresa Weber, ... Stefan Kluge in Annals of Intensive Care
    Article Open access 16 October 2020
  10. Candida albicans and Antifungal Peptides

    Candida albicans , a ubiquitous opportunistic fungal pathogen, plays a pivotal role in human health and disease. As a commensal organism, it normally...

    Camila G. Freitas, Maria Sueli Felipe in Infectious Diseases and Therapy
    Article Open access 08 November 2023
  11. Persistent candidemia in very low birth weight neonates: risk factors and clinical significance

    Background

    The prevalence and risk factors for persistent candidemia among very low birth weight infants are poorly understood. This study aimed to...

    **jian Fu, Yanling Ding, ... Peixu Qin in BMC Infectious Diseases
    Article Open access 12 November 2018
  12. Chronic disseminated candidiasis in a patient with acute leukemia - an illustrative case and brief review for clinicians

    Chronic disseminated candidiasis (CDC) is a severe but rarely seen fungal infection presenting in patients with hematologic malignancies after a...

    Allison Graeter, Dasom Lee, ... Olga Klinkova in BMC Infectious Diseases
    Article Open access 06 March 2024
  13. The Impact of Corticosteroids on the Outcome of Fungal Disease: a Systematic Review and Meta-analysis

    Purpose of Review

    Corticosteroids have a complex relationship with fungal disease — risk for many, benefit for others. This systematic review aims to...

    Zhaolun Li, David W. Denning in Current Fungal Infection Reports
    Article Open access 23 February 2023
  14. Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland

    Echinocandins represent the first-line therapy of candidemia. Echinocandin resistance among Candida spp. is mainly due to acquired FKS mutations. In...

    A. T. Coste, A. Kritikos, ... D. Sanglard in Infection
    Article Open access 13 July 2020
  15. The Lifesaving Impact of Transcatheter Interventions in the Early Post-Fontan Palliation Period

    Despite advancements in postoperative outcomes after Fontan surgery, there remains a risk of suboptimal outcomes and significant morbidity in the...

    Ibrahim Halil Demir, Dursun Muhammed Ozdemir, ... Ahmet Celebi in Pediatric Cardiology
    Article 20 March 2024
  16. Changes in the epidemiology of invasive fungal disease in a Pediatric Hematology and Oncology Unit: the relevance of breakthrough infections

    Background

    Invasive fungal disease (IFD) is a significant cause of morbimortality in children under chemotherapy or hematopoietic stem cell transplant...

    Laura Calle-Miguel, Carmen Garrido-Colino, ... Elena María Rincón-López in BMC Infectious Diseases
    Article Open access 25 May 2023
  17. Case report: Candida krusei spondylitis in an immunocompromised patient

    Background

    Invasive infections with Candida krusei are uncommon and rarely complicated by spondylitis. Previous described cases were solely treated...

    Audrey J. C. Overgaauw, David C. de Leeuw, ... Eef J. Hendriks in BMC Infectious Diseases
    Article Open access 08 October 2020
  18. Coinfection of fungi with SARS-CoV-2 is a detrimental health risk for COVID-19 patients

    Background

    Notable fungal coinfections with SARS-CoV-2 in COVID-19 patients have been reported worldwide in an alarming way. Mucor spp. and Rhizopus ...

    Nahida Baten, Shah Wajed, ... Md. Mijanur Rahman in Beni-Suef University Journal of Basic and Applied Sciences
    Article Open access 04 May 2022
  19. A Review of Healthcare-Associated Fungal Outbreaks in Children

    Purpose of Review

    The aim of this review is to examine healthcare-associated fungal outbreaks (HAFO) in children. Our primary objective is to dissect...

    Cyntia Ibanes-Gutiérrez, Aarón Espinosa-Atri, Ana Cecilia Carbajal-César in Current Fungal Infection Reports
    Article 28 February 2024
Did you find what you were looking for? Share feedback.